"But getting the treatments approved was the easier effort. Now comes the hardest part: actually getting them to patients. It is practically a miracle that this is even possible."
"The obstacles to treatment are myriad: an extremely limited number of medical centers authorized to provide it; the requirement that each patient's cells be edited or have a gene added individually; procedures that are so onerous that not everyone can tolerate them; and a multimillion-dollar price tag and potential insurance obstacles."
[
add
]
[
|
|
...
]